𝛼SK or Search

ENTITY

Regeneron Pharmaceuticals (REGN US)

129

Analysis

Health Care • United States

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

more

Refresh

Exchange Announcement • 06 Oct 2026 19:51

Current Report (Form 8-K | Period ending 2026-10-01)

Exchange Announcement • 01 Oct 2026 04:14

Current Report (Form 8-K | Period ending 2026-09-24)

Exchange Announcement • 30 Jul 2026 18:52

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 30 Jul 2026 18:48

Current Report (Form 8-K | Period ending 2026-07-30)

Exchange Announcement • 06 Jul 2026 19:00

Current Report (Form 8-K | Period ending 2026-07-06)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x